Stockscreener 앱 받기
1.51
3.09%
-0.05
시간 외 거래:
1.51
Opko Health Inc 주식(OPK)의 최신 뉴스
OPKO Health (NASDAQ:OPK) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat
Clinical Laboratory Tests Market See Incredible Growth 2025-2032 | ARUP Laboratories, OPKO Health, Inc., UNILABS - industrytoday.co.uk
Smart tools for monitoring OPKO Health Inc.’s price actionJuly 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Real time pattern detection on OPKO Health Inc. stock2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
NextPlat Issues CEO Shareholder Update Letter - Benzinga
OPKO Health Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
OPKO acquiring company from Barcelona - Law.com
Can machine learning forecast OPKO Health Inc. recoveryPortfolio Return Summary & Safe Entry Zone Identification - newser.com
How OPKO Health Inc. stock performs in weak economyJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
Why OPKO Health Inc. stock attracts global investorsMarket Volume Summary & Reliable Momentum Entry Alerts - newser.com
Technical signs of recovery in OPKO Health Inc.July 2025 Highlights & Fast Moving Market Watchlists - newser.com
How OPKO Health Inc. (XCY) stock reacts to stronger dollarJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
How to manage a losing position in OPKO Health Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - newser.com
Ranking OPKO Health Inc. among high performing stocks via toolsQuarterly Earnings Summary & Entry Point Confirmation Alerts - newser.com
What institutional flow reveals about OPKO Health Inc.Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com
OPKO Health (OPK): Valuation Insights as Clinical Pipeline Progress and Asset Sales Draw Investor Focus - Sahm
Washington Growth Strategies LLC Has $1.79 Million Position in OPKO Health, Inc. $OPK - MarketBeat
OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and CEO Boosts Stake Has the Bull Case Changed? - Sahm
Why OPKO Health (OPK) Is Up 7.7% After Advancing Immuno-Oncology Pipeline and Notable Insider Buying - Sahm
Opko Health (OPK) Reports Fiscal Q2 2025 Results - MSN
What machine learning models say about OPKO Health Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1 - Yahoo Finance
What analysts say about OPKO Health Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
12 Healthcare Stocks with Insider Buying in 2025 - Insider Monkey
OPK Stock Gains Following Q4 Earnings Beat, Gross Margin Expands - MSN
Down Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight | AC Immune, Annovis Bio, Alzheon, OPKO Health, Inc., Aelis Farma - Barchart.com
44% of OPKO Health, Inc. (NASDAQ:OPK) is owned by insiders, and they've been buying recently - Yahoo Finance
Opko Health, Inc. (OPK) Stock Analysis: Unlocking a Potential 151% Upside with Strategic Healthcare Innovations - DirectorsTalk Interviews
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Lowers Position in OPKO Health, Inc. $OPK - MarketBeat
0.31%
2.32%
자본화:
|
볼륨(24시간):